Penserra Capital Management LLC Compugen LTD Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.09 - $7.16 $7,852 - $13,747	-1,920 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $87 - $120	15 Added 0.79%	1,920 $11,000
Q2 2021 Aug 12, 2021	BUY	$6.87 - $9.16 $34 - $45	5 Added 0.26%	1,905 $15,000
Q1 2021 May 13, 2021	SELL	$7.67 - $13.77 $306 - $550	-40 Reduced 2.06%	1,900 $16,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $14,894 - $22,150	1,234 Added 174.79%	1,940 $23,000
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $9,996 - $13,731	706 New	706 $11,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.